HELSINKI, Sept. 18, 2020 /PRNewswire/ -- Optomed and AEYE Health have agreed to enter clinical and commercial collaboration to introduce an AI fundus camera Aurora AEYE. The collaboration includes a ...

Based on the one-year price targets offered by three analysts, the average target price for Optomed PLC (OHEL:OPTOMED) is $4.67, with a high estimate of $5.00 and a low estimate of $4.00. The average ...

Optomed Plc Stock Exchange Release 8 May 2026 at 2.30 p.m., Helsinki Decisions of the Annual General Meeting The Annual General Meeting held on 8 May 2026 adopted the financial statements for the fina ...

May 1 (Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its ...

Based on the one-year price targets offered by 4 analysts, the average target price for Optomed PLC (OHEL:OPTOMED) is $4.48, with a high estimate of $5.00 and a low estimate of $4.00. The average ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

December 5, 2019 – Nasdaq (Nasdaq: NDAQ) announced that trading in Optomed Plc shares (short name: OPTOMED) commence today on the prelist of Nasdaq Helsinki. Optomed is a small cap company within the ...

Optomed's current CEO Seppo Kopsala and the Board of Directors have agreed that Kopsala will leave the CEO position once the new CEO is ready to start. Seppo Kopsala is the founder of Optomed, and he ...

In a procedure that takes a minute, the device takes images from each eye using a special camera and through artificial intelligence captures and analyses data on the retina to help diagnose diseases ...